Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders [NA]
Phase 1 clinical trial update for Gustabor exploring an AI-driven nutritional plan to compensate for chemotherapy-induced taste disorders in…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma [Phase 1]
A Phase 1 study update evaluating upfront CART-BCMA with or without huCART19 in high-risk multiple myeloma. The trial status is ACTIVE_NOT_R…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM) [NA]
A recruiting clinical trial evaluating PET/MR imaging with the CXCR4-targeting tracer [68Ga]Ga-PentixaFor versus standard of care for initia…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders [Phase 2]
Phase 2 clinical trial evaluating myeloablative allogeneic hematopoietic stem cell transplantation from related or unrelated donors for a br…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies [NA]
A clinical trial is recruiting to evaluate an investigational CAR-T cell therapy for hematologic malignancies, including acute lymphoblastic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma [Phase 1, Phase 2]
A clinical trial update for a sequential CAR-T cell therapy targeting BCMA and GPRC5D in relapsed/refractory multiple myeloma (Phase 1/2, re…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma. [Phase 3]
This Phase 3 trial compares venetoclax plus dexamethasone versus pomalidomide plus dexamethasone in t(11;14)-positive relapsed or refractory…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
This document reports a long-term follow-up registry study of Equecabtagene Autoleucel for multiple myeloma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients [NA]
ClinicalTrials.gov entry for a study evaluating Sulpegfilgrastim to prevent neutropenia with infection in newly diagnosed non-transplant mul…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating treatment for high-risk newly diagnosed multiple myeloma with minima…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
This clinical trial update describes a study on decision-making, prognosis, quality of life, and satisfaction in adults with relapsed/refrac…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease [NA]
A clinical trial is evaluating the Go Wish Game to promote advance care planning in patients with leukemia, multiple myeloma, and other onco…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients [NA]
A clinical trial update describes testing a four-drug combination (daratumumab, cabozantinib, pomalidomide, and dexamethasone) for high-risk…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]
A Phase 1 clinical trial evaluating CAR-GPRC5D in relapsed/refractory multiple myeloma or plasma cell leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma [Phase 1]
Phase I study evaluating BCMA-TGF-beta CAR-T cells in relapsed or refractory multiple myeloma; trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma an…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma [EARLY_Phase 1]
An early-phase clinical trial is evaluating a molecular probe that targets BCMA for the clinical diagnosis of multiple myeloma. The study is…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment [Phase 3]
A Phase 3 clinical trial is evaluating different drug combinations to treat newly diagnosed multiple myeloma in patients who are not eligibl…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
A protocol to determine the frequency of variants in the GBA and PSAP genes among patients with monoclonal gammopathy of undetermined signif…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers [Phase 1, Phase 2]
A clinical trial update indicates IDP-023 is being studied as a single agent and in combination with antibody therapies in advanced hematolo…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: The Ambient Light Multiple Myeloma Study [NA]
The ambient light study for multiple myeloma is currently recruiting, according to the clinical trials record.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
Early-phase 1 study evaluating CG-105-12 in patients with relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Personalized Autologous Transplant for Multiple Myeloma [Phase 1]
Emory University is conducting a Phase 1 clinical trial evaluating a personalized autologous transplant approach for patients with multiple …
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Study of 3D189 in Patients With Hematologic Malignancies [Phase 1]
Phase 1 study of 3D189 in hematologic malignancies is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function [Phase 1]
This Phase 1 study investigates belantamab mafodotin as monotherapy in adults with multiple myeloma across varying degrees of renal impairme…